Mitsubishi Tanabe Pharma America Highlights ALS Research at 2022 MDA Clinical & Scientific Conference
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 2 - Multicenter Safety Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Multicenter Safety Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Multicenter Safety Study Today - Breaking & Trending Today
Mitsubishi Tanabe Pharma America Highlights ALS Research at 2022 MDA Clinical & Scientific Conference
JERSEY CITY, N.J., March 11, 2022 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that five presentations on amyotro...
Source: businessinsider.com
Mitsubishi Tanabe Pharma America Announces Presentations at 146th Annual Meeting of the American Neurological Association
/PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that two abstracts on amyotrophic lateral sclerosis (ALS) will be presented...
Source: prnewswire.com
Mitsubishi Tanabe Pharma America Highlights ALS Research at Northeast Amyotrophic Lateral Sclerosis 20th Annual Meeting
/PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that five presentations on amyotrophic lateral sclerosis (ALS) will be shared as...
Source: prnewswire.com